Register entry
- Registered sites
- 0
- Active NDC listings
- 1
- Live patents
- 4
- Exclusivities
- 1
- Countries
- 0
Exclusivity
Patents and exclusivities
4| Patent | Product | Covers | Expiry |
|---|---|---|---|
| 10639297 | QLOSIpilocarpine hydrochloride | product | Aug 2037 |
| 11129812 | QLOSIpilocarpine hydrochloride | use | Aug 2037 |
| 11974986 | QLOSIpilocarpine hydrochloride | use | Aug 2037 |
| 9867810 | QLOSIpilocarpine hydrochloride | product | Aug 2037 |
| Product | Exclusivity | Until |
|---|---|---|
| QLOSIPILOCARPINE HYDROCHLORIDE | NP New product | Oct 2026 |
Catalogue
Marketed products
1| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| Qlosi | Pilocarpine Hydrochloride | solution, ophthalmic | 83661-018NDA |
Compare
Other companies listing pilocarpine hydrochloride
- AbbVie Inc.13 sites · 131 NDC
- MEDISCA Inc.2 sites · 305 NDC
- Bryant Ranch Prepack1 site · 4,357 NDC
- Lannett Company, LLC1 site · 190 NDC
- AvPAK0 sites · 340 NDC
- Amneal Pharmaceuticals NY LLC0 sites · 337 NDC
- C-squared PHARMA S. r.l.0 sites · 26 NDC
- Advanz Pharma (US) Corp.0 sites · 20 NDC
Enquiry
Common questions
- Is Orasis Pharmaceuticals, Inc. FDA approved?
- Orasis Pharmaceuticals, Inc. holds no registered establishment of its own; 1 drug product is listed under its name in the National Drug Code Directory, made at sites registered to other firms.
- What drugs does Orasis Pharmaceuticals, Inc. make?
- 1 product is listed under Orasis Pharmaceuticals, Inc. in the openFDA NDC Directory, most often as solution. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.